Page last updated: 2024-11-05

pirinixic acid and Chronic Disease

pirinixic acid has been researched along with Chronic Disease in 1 studies

pirinixic acid: structure

Chronic Disease: Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2).

Research Excerpts

ExcerptRelevanceReference
"Pulmonary hypertension is a fatal disease; however, its pathogenesis still remains to be elucidated."1.46Activated TAFI Promotes the Development of Chronic Thromboembolic Pulmonary Hypertension: A Possible Novel Therapeutic Target. ( Al-Mamun, E; Kikuchi, N; Kurosawa, R; Miyata, S; Morser, J; Nogi, M; Numano, K; Omura, J; Satoh, K; Satoh, T; Shimokawa, H; Siddique, MA; Sunamura, S; Suzuki, K; Yaoita, N, 2017)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Satoh, T1
Satoh, K1
Yaoita, N1
Kikuchi, N1
Omura, J1
Kurosawa, R1
Numano, K1
Al-Mamun, E1
Siddique, MA1
Sunamura, S1
Nogi, M1
Suzuki, K1
Miyata, S1
Morser, J1
Shimokawa, H1

Other Studies

1 other study available for pirinixic acid and Chronic Disease

ArticleYear
Activated TAFI Promotes the Development of Chronic Thromboembolic Pulmonary Hypertension: A Possible Novel Therapeutic Target.
    Circulation research, 2017, Apr-14, Volume: 120, Issue:8

    Topics: Adult; Animals; Arterial Pressure; Capillary Permeability; Carboxypeptidase B2; Case-Control Studies

2017